# The Discovery of Lovastatin for Lowering Cholesterol

> A 1979 patent by Merck describing the isolation of a fermentation product from Aspergillus fungi that effectively lowers cholesterol levels in the blood.

- **Patent:** US 4231938
- **Original title:** Hypocholesteremic fermentation products and process of preparation
- **Owner:** Merck and Co Inc
- **Granted:** 1980
- **Status:** Public domain (expired)
- **Times cited:** 490
- **Field:** biotech, pharmaceutical

## What it does

The patent details the isolation of a specific compound, initially designated MSD803, produced by fermenting the fungus Aspergillus. This compound, later known as lovastatin, functions as a potent inhibitor of cholesterol synthesis in the human body. The claims specifically protect the chemical structure of this lactone compound and its corresponding hydroxy acid form, which are used to treat high cholesterol and lipid levels.

## What it does NOT cover

- Does not cover synthetic statins developed later that share different chemical backbones.
- Does not cover the general process of fermentation for non-cholesterol-lowering compounds.
- Does not cover the use of the compound for treating conditions unrelated to cholesterol or lipid metabolism.

## The clever bit

The innovation was identifying that a natural byproduct of a common fungus could act as a precise 'off switch' for the enzyme HMG-CoA reductase, which is the rate-limiting step in human cholesterol production.

## Real-world examples

1. Mevacor
2. Generic lovastatin medications

## Why it matters

This patent marks the birth of the statin class of drugs, which became one of the most commercially successful and medically significant pharmaceutical categories in history. It provided a biological solution to heart disease by targeting the body's natural cholesterol production mechanism, fundamentally changing how doctors manage cardiovascular health.

## Frequently asked questions

### What does The Discovery of Lovastatin for Lowering Cholesterol cover?

A 1979 patent by Merck describing the isolation of a fermentation product from Aspergillus fungi that effectively lowers cholesterol levels in the blood.

### Who owns patent US 4231938?

Merck and Co Inc owns this patent, granted in 1980.

### When does this patent expire?

This patent has expired and is now in the public domain — anyone can use the invention freely.

### What is patent US 4231938 cited by?

This patent has been cited by 490 later patents that build on its ideas.

### What problem does this patent solve?

This patent marks the birth of the statin class of drugs, which became one of the most commercially successful and medically significant pharmaceutical categories in history. It provided a biological solution to heart disease by targeting the body's natural cholesterol production mechanism, fundamentally changing how doctors manage cardiovascular health.

### What does this patent NOT cover?

Does not cover synthetic statins developed later that share different chemical backbones.

**Full plain-English explainer:** https://patentbrief.org/patent/us/4231938/statin-cholesterol-lovastatin

**Original patent:** https://patents.google.com/patent/US4231938

---

_Source: PatentBrief — https://patentbrief.org. Patent facts are from public records; the plain-English explanation is PatentBrief's._


## Related patents

Semantically similar inventions in the PatentBrief corpus:

- [How a Cholesterol-Lowering Drug Molecule Was Patented](https://patentbrief.org/patent/us/5273995/viagra-sildenafil) — This patent protects the specific chemical structure of a molecule designed to lower cholesterol, including its various salt forms and its use in medicine.
- [The Chemical Formula for Atorvastatin, the Active Ingredient in Lipitor](https://patentbrief.org/patent/us/4681893/prozac-fluoxetine) — This patent describes the chemical structure of a class of molecules designed to block the enzyme responsible for cholesterol production in the human body.
- [Chemical Compounds for Fighting Bacterial and Yeast Infections](https://patentbrief.org/patent/us/4147780/timoptic-timolol) — A 1977 patent for a specific class of amino-phosphonous acid chemicals designed to act as antibiotics against bacteria and yeast.
- [The Discovery of Aspartame as a Sugar Substitute](https://patentbrief.org/patent/us/3492131/aspartame-sweetener) — This 1966 patent identifies specific chemical compounds, known as aspartylphenylalanine esters, that provide intense sweetness for food and drinks without using sugar.
- [Chemical Compounds for Treating Hepatitis C Virus](https://patentbrief.org/patent/us/8822430/epclusa-sofosbuvir-velpatasvir) — A patent describing specific chemical structures designed to stop the Hepatitis C virus from replicating in humans.